Da-Jung Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Da-Jung Kim has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Ho Sup Lee
Department of Internal Medicine Kosin University College of Medicine Busan South Korea
18 shared publications - Hwayoung Yun
Pusan National University
16 shared publications - Hyung Seok Kim
Department of Biochemistry, Kosin University College of Medicine, Seo-gu, Busan 49267, Republic of Korea
16 shared publications - Jee-Yeong Jeong
Department of Biochemistry, Kosin University College of Medicine, Busan, Republic of Korea
16 shared publications - Jeyun Jo
Department of Pathology Stanford University School of Medicine Stanford United States
16 shared publications - Ji An Kang
R&D Center, NexThera Co., Ltd., Busan, Republic of Korea
16 shared publications
Latest Publications
- Open Access
- 29 May 2026
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry
- 29 May 2026
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
Open AccessTreatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
HR-19011, one of the squaramide-based compounds, specifically induced eIF2α phosphorylation in an HRI-dependent manner
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
HR-19011, one of the squaramide-based compounds, specifically induced eIF2α phosphorylation in an HRI-dependent manner
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S9 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Schematic representation of the proposed mechanism of action of HR-19011 in K562 cells
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Schematic representation of the proposed mechanism of action of HR-19011 in K562 cells
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
List of antibodies used in western blotting
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
List of antibodies used in western blotting
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Production of recombinant HRI and anti-HRI antiserum
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Production of recombinant HRI and anti-HRI antiserum
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Sequences of primers used for PCR
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Sequences of primers used for PCR
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
IC50 values of squaramide-based compounds in K562 cells with normal and reduced HRI expression levels
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
IC50 values of squaramide-based compounds in K562 cells with normal and reduced HRI expression levels
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Expression analysis of eIF2α kinases in 173 leukemic cell lines
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Expression analysis of eIF2α kinases in 173 leukemic cell lines
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Protein expression analysis of ISR inducers and eIF2α in selected hematologic cancer cell lines
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Protein expression analysis of ISR inducers and eIF2α in selected hematologic cancer cell lines
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Western blotting analysis of eIF2α phosphorylation induced by 37 compounds in K562 cells
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from A Novel Squaramide Derivative, HR-19011, Induces the Integrated Stress Response via the HRI–eIF2α–ATF4 Pathway, Effectively Inhibiting Hematologic Malignancies
Western blotting analysis of eIF2α phosphorylation induced by 37 compounds in K562 cells